ibrutinib,zanubrutinib
abbvie,beigene,janssen
['leukemia', 'lymphoma', 'zanubrutinib', 'cll', ' ibru', 'alpine']
jennifer brown, md, phd share her results of the alpine randomized phase 3 study, which shows zanubrutinib demonstrates superior progression-free survival for treatment of relapsed/refractory chronic lymphocytic leukemia &amp; small lymphocytic lymphoma #ash22 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090